• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过拉曼、原子力和表面等离子体共振光谱研究两亲性细胞穿透肽 p28 与野生型和突变型 p53 的结合。

Binding of Amphipathic Cell Penetrating Peptide p28 to Wild Type and Mutated p53 as studied by Raman, Atomic Force and Surface Plasmon Resonance spectroscopies.

机构信息

Biophysics and Nanoscience Centre, DEB, Università della Tuscia, Viterbo, Italy; Department of Science, University Roma Tre, Rome, Italy.

Biophysics and Nanoscience Centre, DEB, Università della Tuscia, Viterbo, Italy.

出版信息

Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):910-921. doi: 10.1016/j.bbagen.2017.01.022. Epub 2017 Jan 24.

DOI:10.1016/j.bbagen.2017.01.022
PMID:28126403
Abstract

BACKGROUND

Mutations within the DNA binding domain (DBD) of the tumor suppressor p53 are found in >50% of human cancers and may significantly modify p53 secondary structure impairing its function. p28, an amphipathic cell-penetrating peptide, binds to the DBD through hydrophobic interaction and induces a posttranslational increase in wildtype and mutant p53 restoring functionality. We use mutation analyses to explore which elements of secondary structure may be critical to p28 binding.

METHODS

Molecular modeling, Raman spectroscopy, Atomic Force Spectroscopy (AFS) and Surface Plasmon Resonance (SPR) were used to identify which secondary structure of site-directed and naturally occurring mutant DBDs are potentially altered by discrete changes in hydrophobicity and the molecular interaction with p28.

RESULTS

We show that specific point mutations that alter hydrophobicity within non-mutable and mutable regions of the p53 DBD alter specific secondary structures. The affinity of p28 was positively correlated with the β-sheet content of a mutant DBD, and reduced by an increase in unstructured or random coil that resulted from a loss in hydrophobicity and redistribution of surface charge.

CONCLUSIONS

These results help refine our knowledge of how mutations within p53-DBD alter secondary structure and provide insight on how potential structural alterations in p28 or similar molecules improve their ability to restore p53 function.

GENERAL SIGNIFICANCE

Raman spectroscopy, AFS, SPR and computational modeling are useful approaches to characterize how mutations within the p53DBD potentially affect secondary structure and identify those structural elements prone to influence the binding affinity of agents designed to increase the functionality of p53.

摘要

背景

肿瘤抑制因子 p53 的 DNA 结合域(DBD)内的突变存在于超过 50%的人类癌症中,并且可能显著改变 p53 的二级结构,从而损害其功能。p28 是一种两亲性细胞穿透肽,通过疏水相互作用与 DBD 结合,并诱导野生型和突变型 p53 的翻译后增加,恢复其功能。我们使用突变分析来探索哪些二级结构元素可能对 p28 结合至关重要。

方法

使用分子建模、拉曼光谱、原子力光谱(AFS)和表面等离子体共振(SPR)来识别定点和自然发生的突变 DBD 的哪些二级结构可能由于疏水性的离散变化和与 p28 的分子相互作用而发生改变。

结果

我们表明,改变 p53 DBD 中非突变和突变区域疏水性的特定点突变会改变特定的二级结构。p28 的亲和力与突变 DBD 的β-折叠含量呈正相关,并且由于疏水性丧失和表面电荷重新分布导致无规卷曲或无规卷曲的增加而降低。

结论

这些结果有助于我们更深入地了解 p53-DBD 内的突变如何改变二级结构,并深入了解 p28 或类似分子的潜在结构改变如何提高其恢复 p53 功能的能力。

一般意义

拉曼光谱、AFS、SPR 和计算建模是用于表征 p53DBD 内的突变如何潜在影响二级结构并识别那些易于影响设计用于增加 p53 功能的药物结合亲和力的结构元素的有用方法。

相似文献

1
Binding of Amphipathic Cell Penetrating Peptide p28 to Wild Type and Mutated p53 as studied by Raman, Atomic Force and Surface Plasmon Resonance spectroscopies.通过拉曼、原子力和表面等离子体共振光谱研究两亲性细胞穿透肽 p28 与野生型和突变型 p53 的结合。
Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):910-921. doi: 10.1016/j.bbagen.2017.01.022. Epub 2017 Jan 24.
2
Interaction of the anticancer p28 peptide with p53-DBD as studied by fluorescence, FRET, docking and MD simulations.荧光、FRET、对接和 MD 模拟研究抗癌 p28 肽与 p53-DBD 的相互作用。
Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):342-350. doi: 10.1016/j.bbagen.2018.11.003. Epub 2018 Nov 10.
3
A nanotechnological, molecular-modeling, and immunological approach to study the interaction of the anti-tumorigenic peptide p28 with the p53 family of proteins.一种纳米技术、分子建模和免疫学方法,用于研究抗肿瘤肽 p28 与 p53 蛋白家族的相互作用。
Int J Nanomedicine. 2014 Apr 10;9:1799-813. doi: 10.2147/IJN.S58465. eCollection 2014.
4
p28, an anionic cell-penetrating peptide, increases the activity of wild type and mutated p53 without altering its conformation.p28是一种阴离子细胞穿透肽,它能提高野生型和突变型p53的活性,而不改变其构象。
Mol Pharm. 2013 Sep 3;10(9):3375-83. doi: 10.1021/mp400221r. Epub 2013 Aug 16.
5
Surface Plasmon Resonance Sensing of Biorecognition Interactions within the Tumor Suppressor p53 Network.基于表面等离子体共振的肿瘤抑制因子 p53 网络中生物识别相互作用的传感研究。
Sensors (Basel). 2017 Nov 20;17(11):2680. doi: 10.3390/s17112680.
6
p28, a first in class peptide inhibitor of cop1 binding to p53.p28,一种首创的 cop1 肽抑制剂,可与 p53 结合。
Br J Cancer. 2013 Jun 25;108(12):2495-504. doi: 10.1038/bjc.2013.266. Epub 2013 Jun 4.
7
Interaction of mutant p53 with p73: a Surface Plasmon Resonance and Atomic Force Spectroscopy study.突变型p53与p73的相互作用:表面等离子体共振和原子力光谱研究
Biochim Biophys Acta. 2014 Jun;1840(6):1958-64. doi: 10.1016/j.bbagen.2014.02.014. Epub 2014 Feb 24.
8
Binding kinetics of mutant p53R175H with wild type p53 and p63: A Surface Plasmon Resonance and Atomic Force Spectroscopy study.突变型p53R175H与野生型p53和p63的结合动力学:表面等离子体共振和原子力光谱研究
Biophys Chem. 2017 Sep;228:55-61. doi: 10.1016/j.bpc.2017.07.002. Epub 2017 Jul 5.
9
Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.抑制性突变恢复突变型p53序列特异性DNA结合及反式激活作用的结构基础
J Mol Biol. 2009 Jan 9;385(1):249-65. doi: 10.1016/j.jmb.2008.10.063. Epub 2008 Oct 30.
10
Modelling the interaction between the p53 DNA-binding domain and the p28 peptide fragment of Azurin.模拟 p53 DNA 结合域与天青蛋白 p28 肽片段之间的相互作用。
J Mol Recognit. 2011 Nov-Dec;24(6):1043-55. doi: 10.1002/jmr.1153.

引用本文的文献

1
Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions.基于肽的癌症治疗药物:当前应用与未来方向。
Int J Mol Sci. 2023 Aug 18;24(16):12931. doi: 10.3390/ijms241612931.
2
The brain-penetrant cell-cycle inhibitor p28 sensitizes brain metastases to DNA-damaging agents.具有脑穿透性的细胞周期抑制剂p28可使脑转移瘤对DNA损伤剂敏感。
Neurooncol Adv. 2023 Apr 11;5(1):vdad042. doi: 10.1093/noajnl/vdad042. eCollection 2023 Jan-Dec.
3
Targeting p53 pathways: mechanisms, structures, and advances in therapy.
靶向 p53 通路:机制、结构和治疗进展。
Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1.
4
Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer.细胞穿透肽(CPPs)作为癌症的治疗和诊断剂
Cancers (Basel). 2022 Nov 11;14(22):5546. doi: 10.3390/cancers14225546.
5
When is an obscurin variant pathogenic? The impact of Arg4344Gln and Arg4444Trp variants on protein-protein interactions and protein stability.什么时候 obscurin 变异是致病的?Arg4344Gln 和 Arg4444Trp 变异对蛋白-蛋白相互作用和蛋白稳定性的影响。
Hum Mol Genet. 2021 Jun 9;30(12):1131-1141. doi: 10.1093/hmg/ddab010.
6
Anticancer Actions of Azurin and Its Derived Peptide p28.天青蛋白及其衍生肽 p28 的抗癌作用。
Protein J. 2020 Apr;39(2):182-189. doi: 10.1007/s10930-020-09891-3.
7
Raman Evidence of p53-DBD Disorder Decrease upon Interaction with the Anticancer Protein Azurin.拉曼光谱证据表明,p53-DBD 结构域与抗癌蛋白铜绿假单胞菌外毒素 A 相互作用后发生构象变化。
Int J Mol Sci. 2019 Jun 24;20(12):3078. doi: 10.3390/ijms20123078.
8
Membrane Active Peptides and Their Biophysical Characterization.膜活性肽及其生物物理特性分析。
Biomolecules. 2018 Aug 22;8(3):77. doi: 10.3390/biom8030077.
9
Surface Plasmon Resonance Sensing of Biorecognition Interactions within the Tumor Suppressor p53 Network.基于表面等离子体共振的肿瘤抑制因子 p53 网络中生物识别相互作用的传感研究。
Sensors (Basel). 2017 Nov 20;17(11):2680. doi: 10.3390/s17112680.
10
Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.细菌铜蓝蛋白天青蛋白劫持细胞信号网络:蛋白质-蛋白质相互作用与癌症治疗。
Protein Sci. 2017 Dec;26(12):2334-2341. doi: 10.1002/pro.3310. Epub 2017 Oct 27.